Fondaparinux sodium
Sponsors
Region Midtjylland, Graduate School of Kyushu University, GlaxoSmithKline, Schering-Plough, Melbourne Health
Conditions
Acute Myocardial Infarction (AMI)AtaxiaCardiovascular DiseaseCervical CancerCoronary DiseaseEmbolism, PulmonaryEndometrial CancerEndovenous Laser Ablation
Phase 2
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
WithdrawnNCT00060554
Start: 2003-04-30Target: 300Updated: 2009-11-03
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
CompletedNCT00381888
Start: 2007-01-31End: 2009-01-31Updated: 2017-12-28
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
CompletedNCT00436787
Start: 2007-02-28End: 2007-12-31Target: 21Updated: 2008-05-16
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
CompletedNCT00531843
Start: 2007-12-31End: 2008-06-30Updated: 2013-12-24
Phase 3
A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).
CompletedNCT00038961
Start: 2001-11-30End: 2004-10-31Updated: 2016-09-01
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients
CompletedNCT00333021
Start: 2006-05-31End: 2007-02-28Updated: 2009-07-10
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
CompletedNCT00843492
Start: 2008-12-31End: 2010-06-30Updated: 2016-03-16
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
CompletedNCT00911157
Start: 2008-06-30End: 2009-11-30Updated: 2016-11-23
The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
CompletedNCT00981409
Start: 2007-07-31End: 2008-12-31Updated: 2016-12-16
Aspirin versus Aspirin and Fondaparinux Prior to Early Invasive Strategy in Patients with NSTEMI
RecruitingCTIS2024-517229-18-00
Start: 2025-04-30Target: 5076Updated: 2025-09-22
Phase 4
Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein
CompletedNCT05001776
Start: 2021-08-16End: 2023-12-01Updated: 2023-12-20
Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction
RecruitingNCT06710184
Start: 2025-05-01End: 2029-07-01Target: 5076Updated: 2025-06-22
Unknown Phase
Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
TerminatedNCT00256100
Start: 2004-06-30End: 2007-12-31Updated: 2017-04-12
Hemorrhage Risk Prescribed Arixtra
CompletedNCT01064362
Start: 2010-01-31End: 2010-06-30Updated: 2015-05-12
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology)
CompletedNCT01390883
Start: 2008-12-31End: 2013-10-31Updated: 2015-03-27
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery
CompletedNCT01390896
Start: 2009-09-30End: 2013-01-31Updated: 2014-07-28
Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)
CompletedNCT01428544
Start: 2012-03-31End: 2015-06-30Updated: 2015-07-15
Special Drug Use Investigation for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment
CompletedNCT01428531
Start: 2012-01-31End: 2015-06-30Updated: 2015-07-15
Incidence of Venous Thromboembolism Following Laparoscopic Surgery for Gastrointestinal Cancer: A Single-Center, Prospective Cohort Study
Active, not recruitingJPRN-UMIN000017475
Start: 2012-05-12Target: 100Updated: 2025-07-18